The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention

Cardiovascular Revascularization Medicine : Including Molecular Interventions
Mohammad-Reza Movahed, Samuel M Butman

Abstract

No-reflow is one of the major causes of postinterventional rise of cardiac enzyme and myocardial infarction (MI). This complication is associated with substantial morbidity and mortality after percutaneous coronary intervention (PCI). During and after a no-reflow episode, the patient can suffer from severe chest pain, hypotension, bradycardia, hemodynamic collapse, MI, congestive heart failure, and death. Every effort should be taken to reduce the incidence of this complication. The distal embolic protection device has been shown to decrease this risk in saphenous vein graft (SVG) interventions but not in native coronaries. On the other hand, the use of glycoprotein IIb/IIIa receptor antagonists have been effective in reducing the occurrence of no-reflow during PCI of native coronaries but not during SVG interventions. The treatment of no-reflow is based on the intracoronary administrations of medications that induce maximal vasodilatation in small distal coronary vasculature. The most commonly used drugs in this setting are adenosine, nitroprusside, and verapamil. The goal of this study was to review the pathogenesis and treatment of no-reflow in patients undergoing PCI.

References

Dec 1, 1974·The Journal of Clinical Investigation·R A KlonerR B Jennings
Apr 15, 1995·The American Journal of Cardiology·K M AbboR D Safian
Dec 24, 1998·Catheterization and Cardiovascular Diagnosis·T A FischellA Kloostra
Oct 19, 1999·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·G P HannaR W Smalling
May 15, 2001·European Heart Journal·E Eeckhout, M J Kern
Nov 1, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Kimberly A SkeldingWilliam W O'Neill
Feb 7, 2003·Journal of the American College of Cardiology·Katsuomi IwakuraKenshi Fujii
Aug 19, 2003·Heart·G Sangiorgi, A Colombo
Oct 1, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Lloyd W KleinUNKNOWN Interventional Cardiology Committee of the Society of Cardiac Angiography and Interventions
Nov 19, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Zheng HuangJun Tanigawa
Apr 6, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Cem BarcinAmir Lerman
Jun 2, 2004·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Francesco BellandiRoberto Piero Dabizzi
Oct 2, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Sang Yup LimJung Chaee Kang
Feb 16, 2005·The American Journal of the Medical Sciences·R V KellyG A Stouffer
Mar 3, 2005·JAMA : the Journal of the American Medical Association·Gregg W StoneUNKNOWN Enhanced Myocardial Efficacy and Recovery by Aspiration of Liberated Debris (EMERALD) Investigators

❮ Previous
Next ❯

Citations

Jan 9, 2010·Expert Opinion on Emerging Drugs·Chiara LazzeriG F Gensini
Aug 26, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Gaetano TanzilliEnrico Mangieri
Aug 12, 2009·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Gabriel MaluendaRon Waksman
May 3, 2011·The American Journal of Cardiology·Khurshid AhmedUNKNOWN Other Korea Acute Myocardial Infarction Registry Investigators
Nov 19, 2014·Nature Reviews. Cardiology·Ryanne P BetgemNiels van Royen
Nov 24, 2016·Medizinische Klinik, Intensivmedizin und Notfallmedizin·K M HeinrothR Prondzinsky
Nov 9, 2014·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Eftal Murat BakirciErgun Topal
Sep 24, 2020·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Mohammad Reza Movahed
Oct 23, 2018·World Journal of Cardiology·Jaime González-MonteroRamón Rodrigo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.